Join the club for FREE to access the whole archive and other member benefits.

Joshua McClure

Founder, CEO and Chairman at Maxwell Biosciences

Joshua is an engineer with over 20 years of experience as a CEO. He is a multi-patent inventor including anti-viral applications of Maxwell’s platform. His background includes leading engineering teams, as well as military intelligence and commercial applications.  He is a pioneer in the field of plasma proteomics and biomimetics. He has a wide ranging interest in physics, information theory and nanobiology. He is a graduate of the USAF Academy, with a B.S. in Management. He holds a Masters of Business Administration from the University of Massachusetts. 

Visit website: https://maxwellbiosciences.com/team

 joshuamcclure

 joshuamcclure

See also: Company Maxwell Biosciences - Biotechnology company focused on the treatment of infectious diseases

Details last updated 21-Oct-2022

Joshua McClure is also referenced in the following:

ARDD 2023 - 10th Aging Research & Drug Discovery Meeting

28-Aug-2023 to 01-Sep-2023

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen

Longevity Summit Dublin 2023

17-Aug-2023 to 20-Aug-2023
Club discount available - click here

Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers

Joshua McClure Blog Posts

Highlights from Longevity Summit Dublin 2023
24-Aug-2023

Highlights from Longevity Summit Dublin 2023

Key points and slides from the leading longevity conference hosted by Aubrey de Grey

Joshua McClure News

Reason reports back from Age-Related Disease Therapeutics Summit 2023

Fight Aging! - 16-Jun-2023

Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years

Read more...

Reason reports back from October's Rejuvenation Startup Summit

Fight Aging! - 19-Oct-2022

Some really exciting developments with quite a few in clinical trials

Read more...